Novoclem Therapeutics Inc

Closed
Call
Website
4222 Emperor Blvd Ste 470
Durham, NC 27703
+1 (919) 647-4990
https://www.vasttherapeutics.com

Novoclem Therapeutics Inc, based in Durham, NC, is dedicated to developing innovative medicines aimed at treating chronic respiratory diseases, including cystic fibrosis and bronchiectasis. The company focuses on addressing the root causes of these debilitating conditions to improve patients' quality of life and enable them to engage in everyday activities.

With a commitment to reshaping the future of respiratory medicine, Novoclem Therapeutics is actively advancing its pipeline through various stages of development, including preclinical and clinical phases. The company has received recognition for its efforts, including grants and designations from the FDA, underscoring its role in combating chronic lung diseases that affect millions worldwide.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Business services, nec, nec, Nonresidential construction, nec, nec, Real estate managers

Liquidia Technologies

Liquidia Technologies is developing highly precise particle-based vaccines and therapeutics for the prevention and treatment of human disease. Combining a deep understanding of particle-based drug development with breakthrough small molecule and biological therapeutics, Liquidia is engineering vaccines and therapies that have the potential to dramatically improve the quality of human life. The company was founded in 2004 and is located in Research Triangle Park, North Carolina.
Real estate managers, Drugs acting on the respiratory system, Drugs and drug proprietaries

Chiesi USA, Inc

Critical Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The company owns rights to the asthma drug ZYFLO, or zileuton tablets, in addition to other formulations of zileuton throughout the world. ZYFLO is one of the only five lipoxygenase inhibitors approved for marketing by the Untied States Food and Drug Administration and is indicated for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. Critical Therapeutics s commercialization effort for ZYFLO is done with nearly 80 people on the company s specialty sales force. Headquartered in Lexington, Mass., Critical Therapeutics is a privately owned company.
Services, nec, nec, Real estate managers

Kbi Biopharma

KBI Biopharma, located in Durham, NC, is a global Contract Development and Manufacturing Organization (CDMO) that specializes in providing innovative biologic solutions for the development and manufacturing of biopharmaceuticals. With a focus on driving breakthroughs in biopharmaceutical development, KBI Biopharma offers comprehensive services for mammalian and microbial cell line development, process development, analytical development, formulation development, and clinical and commercial manufacturing. By offering cutting-edge, collaborative, and compliant services, KBI Biopharma is redefining the industry with its next-generation CDMO services. The company's expertise in cell line development, process development, analytical development, and manufacturing services for new biologics showcases its commitment to delivering high-quality biopharmaceutical solutions that positively impact the lives of patients worldwide. Generated from the website
United States›North Carolina›Durham›Novoclem Therapeutics Inc

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.